Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12603759 | 0.81 | FFAR3 (0.38) | FFAR3 | |
| SCHEMBL26110096 | 0.79 | CYP2C19 (0.36) | FFAR3 | |
| SCHEMBL1116297 | 0.75 | CYP2C19 (0.40) | FFAR3 | |
| SCHEMBL31314229 | 0.75 | FFAR3 (0.31) | FFAR3 | |
| SCHEMBL527610 | 0.71 | — | — | |
| SCHEMBL1116298 | 0.68 | FFAR3 (0.42) | FFAR3 | |
| SCHEMBL11235708 | 0.67 | — | — | |
| SCHEMBL3620449 | 0.67 | FFAR3 (0.39) | FFAR3 | |
| SCHEMBL21670229 | 0.67 | FFAR3 (0.39) | FFAR3 | |
| SCHEMBL28986141 | 0.67 | CYP2C19 (0.34) | FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7749539-B2 | Therapy for tumor or bone infections; antitumor agents; anticancer agents; bactericides; antiinflammatory agents; administering by injection | EFRAT BIOPOLYMERS LTD. (IL) | 2010-07-06 | — | — | US | claimed |
| US-20120225283-A1 | OPTICAL FILM HAVING ANTISTATIC LAYER, AND ANTIREFLECTION FILM, POLARIZING PLATE AND IMAGE DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2012-09-06 | — | — | US | disclosed |
| US-7749539-B2 | Therapy for tumor or bone infections; antitumor agents; anticancer agents; bactericides; antiinflammatory agents; administering by injection | EFRAT BIOPOLYMERS LTD. (IL) | 2010-07-06 | — | — | US | disclosed |
| US-20040161464-A1 | Polymeric formulations for drug delivery | EFRAT BIOPOLYMERS LTD. | 2004-08-19 | — | — | US | disclosed |
| US-4314055-A | X-RAY CONTRAST AGENTS | MALLINCKRODT, INC. (US) | 1982-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040161464-A1 | Polymeric formulations for drug delivery | SBDS, AR, CD47 | FFAR3 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.